Skip to content
sellWeak cluster of 210b5-1 plan

Marvin Johnson sold $869 of MRNS

director at MARINUS PHARMACEUTICALS, INC.. 1,610 shares at an average of $0.54, traded Jan 21, 2025, filed Jan 23, 2025.

Warning score
8
Value
$869
1,610 shares
Holdings after
12,490
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $869 at market
    0
  • Share of holdings sold
    Sold 11% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-25-001928, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 21, 2025SOpen-market sale
Common Stock10b5-1
-1,610$0.54$86912,490Jan 23, 2025

Related signals

Other insiders at MARINUS PHARMACEUTICALS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
10Weak
MRNSbuy10b5-1
MARINUS PHARMACEUTICALS, INC.
Scott Braunstein
CHAIRMAN AND CEO
$6,526
5,933 shares
+2%
8Weak
MRNSsell 210b5-1
MARINUS PHARMACEUTICALS, INC.
Elan Ezickson
director
$864
1,600 shares
-13%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Marvin Johnson sold $869 of MRNS | InsiderTell